In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure

Liver International

Volumn 28, Issue 8, 2008, Pages 1095-1103

  Verma, Ashish ^a   Saraswat, Vivek Anand ^a   Radha Krishna, Y ^a   Nath, Kavindra ^a   Thomas, M Albert ^b   Gupta, Rakesh Kumar ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute liver failure; Acute on chronic liver failure; Chronic liver disease; Magnetic resonance imaging; MRS

Indexed keywords

BILIRUBIN; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; ASPARTIC ACID; DRUG DERIVATIVE; N-ACETYLASPARTATE; UNCLASSIFIED DRUG;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEMOCHROMATOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; IN VIVO STUDY; LIVER FAILURE; MALE; METABOLITE; METABOLITE ALTERATION; NEUROPATHOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE; VIRUS HEPATITIS; WILSON DISEASE; ADOLESCENT; AGED; BRAIN; CASE CONTROL STUDY; CHRONIC DISEASE; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; BRAIN; CASE-CONTROL STUDIES; CHOLINE; CHRONIC DISEASE; CREATINE; FEMALE; GLUTAMIC ACID; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; INOSITOL; LIVER FAILURE, ACUTE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 48949105431     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01648.x     Document Type: Article

References (38)

1. Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 2002; 22: 5-13.
2. Jeyamani K. Hepatitis E and acute-on-chronic liver failure. Ind J Gastroenterol 2004; 23: 45-6.
3. Jalan R, Williams R. Acute-on-chronic-liver-failure: Pathophysiological basis of therapeutic options. Blood Purif 2002; 20: 252-61.
4. Acharya SK, Dasarathy S, Kumer TL, et al. Fulminant hepatic failure in a tropical population: Clinical course, cause, and early predictors of outcome. Hepatology 1996; 23: 1448-55.
5. Kumar A, Aggarwal R, Naik SR, et al. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Ind J Gastroenterol 2004; 23: 59-62.
6. Hamid SS, Atiq M, Shehzad F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002; 36: 474-8.
7. Radhakrishna Y, Saraswat VA, Sachdeva S, et al. Acute-on-chronic liver failure (ACLF) due to hepatitis A and E superinfection: Six years experience. Ind J Gastroenterol 2006; 25: A141.
8. Vaquero J, Fontana RJ, Larson AM, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11: 1581-9.
9. Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: In vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis 2005; 20: 181-92.
10. Lodi R, Tonon C, Stracciari A, et al. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004; 62: 762-6.
11. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006; 43: 698-706.
12. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125-38.
13. Martinez-Hernandez A, Bell KP, Norenberger MD. Glutamine synthetase: glial localization in brain. Science 1977; 195: 1356-85.
14. Brusilow SW, Traystman R. Hepatic encephalopathy. N Engl J Med 1986; 314: 786-7.
15. Mass AM, Biebuyck JF, Shelly K, Hawkins RA. Regional blood brain barrier permeability to amino acids after portacaval anastomosis. J Neurochem 1982; 38: 705-13.
16. Rose C, Ytrebø LM, Davies NA, et al. Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. Hepatology 2007; 46: 1883-92.
17. Sandro V, Tiziana G, Carlo R, et al. Fulminant hepatitis associated with hepatitis a virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338: 286-90.
18. Jalan R, Williams R. The inflammatory basis of intracranial hypertension in acute liver failure. J Hepatol 2001; 34: 940-2.
19. Rovira A, Grive E, Pedraza S, Rovira A, Alonso J. Magnetization transfer ratio values and proton MR spectroscopy of normal appearing cerebral white matter in patients with liver cirrhosis. Am J Neruroradiol 2001; 22: 1137-42.
20. Rovira A, Cordoba J, Raguer N, Alonso J. Magnetic resonance imaging measurement of brain edema in patients with liver disease: Resolution after liver transplantation. Curr Opin Neurol 2002; 15: 731-7.
21. Cordoba J, Gottstein J, Blei AT. Glutamine, myoinositol, and organic osmolytes after portacaval anastomosis in the rat: Implications for ammonia-induced brain edema. Hepatology 1996; 27: 919-23.
22. Tandon BN, Bernauau J, O'Grady J, et al. Recommendations of the International Association for the study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol 1999; 14: 403-4.
23. Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy: A controlled, double-blind clinical trial. Am J Dig Dis 1978; 23: 398-406.
24. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14: 260-4.
25. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 288-9.
26. Zwingmann C. Nuclear magnetic resonance studies in experimental animal models of hepatic encephalopathy. In: Haussinger D, Kirchies G, Schliess F, eds. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht, the Netherlands: Springer Verlag, 2006; 202-28.
27. +/myo-inositol transport is regulated by basolateral tonicity in Madin-Darby canine kidney cells. J Clin Invest 1996; 97: 263-7.
28. Gupta RK, Saraswat VA, Poptani H, et al. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure. Am J Gastroenterol 1993; 88: 670-4.
29. Shawcross DL, Balata S, Olde Damink SWM, et al. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol Gastrointest Liver Physiol 2004; 287: 503-9.
30. Ibsen L, Strange K. In situ localization and osmotic regulation of the Na(+)-myo-inositol cotransporter in rat brain. Am J Physiol 1996; 271: F877-85.
31. Nyberg SL, Cerra FB, Gruetter R. Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg 1998; 4: 158-65.
32. Ulmer S, Flemming K, Hahn A, Stephani U, Jansen O. Detection of acute cytotoxic changes in progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome) using diffusion-weighted MRI and MR spectroscopy. J Comput Assist Tomogr 2002; 26: 641-6.
33. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 19-27.
34. Geissler A, Lock G, Fründ R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997; 25: 48-54.
35. Galea E, Estrada C. Quabain-sensitive choline transport system in capillaries isolated from bovine brain. J Neurochem 1992; 59: 936-41.
36. Klein J, Gonzalez R, Koppen A, Loffelholz K. Free choline and choline metabolites in rat brain and body fluids: Sensitive determination and implications for choline supply to the brain. Neurochem Int 1993; 22: 293-300.
37. Rao VL, Therrien G, Butterworth RF. Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy. Metab Brain Dis 1994; 9: 401-7.
38. Chawla RK, Wolf DC, Kutner MH. Choline may be essential nutrient in malnourished patients with cirrhosis. Gasteroenterology 1989; 97: 1514-20.